{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Questionnaire+1&page=68", "query": { "intervention": "Questionnaire 1", "page": 68 }, "page_size": 10 }, "pagination": { "page": 68, "page_size": 10, "total_count": 2380, "total_pages": 238, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Questionnaire+1&page=69&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Questionnaire+1&page=67&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-11T21:39:54.652Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05535192", "title": "TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Stage III Breast Cancer", "Breast Cancer Female", "Stage I Breast Cancer", "Stage II Breast Cancer" ], "interventions": [ { "name": "THRIVE", "type": "BEHAVIORAL" }, { "name": "Health Education Support Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "FEMALE", "summary": "65 Years and older · Female only" }, "enrollment_count": 270, "start_date": "2023-03-20", "completion_date": "2028-02-01", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 4, "location_summary": "Boston, Massachusetts • Cleveland, Ohio • Pittsburgh, Pennsylvania + 1 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "State College", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05535192" }, { "nct_id": "NCT01596972", "title": "The Role of a Semi-Quantitative Urine Pregnancy Test and Pregnancy Questionnaire After Uterine Evacuation for Undesired Pregnancy of Uncertain Location", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Follow-up After Uterine Evacuation" ], "interventions": [ { "name": "dBest semi-quantitative urine pregnancy test", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Planned Parenthood League of Massachusetts", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 51, "start_date": "2012-06", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2014-07-01", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01596972" }, { "nct_id": "NCT05159583", "title": "In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Rural Homes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dementia", "Mild Cognitive Impairment", "Alzheimer Disease" ], "interventions": [ { "name": "In-Home Technology System", "type": "DEVICE" }, { "name": "Limited In-Home Technology", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of California, Berkeley", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2022-08-22", "completion_date": "2024-01-30", "has_results": true, "last_update_posted_date": "2025-02-25", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 1, "location_summary": "Berkeley, California", "locations": [ { "city": "Berkeley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05159583" }, { "nct_id": "NCT05699083", "title": "Outcomes After Weight Loss Surgery in Low-Risk Patients", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Weight Loss", "Bariatric Surgery" ], "interventions": [ { "name": "Body Image/Self-Esteem Questionnaires", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Dr. Feiz & Associates", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 20, "start_date": "2022-03-11", "completion_date": "2026-01-12", "has_results": false, "last_update_posted_date": "2023-01-26", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 1, "location_summary": "Beverly Hills, California", "locations": [ { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05699083" }, { "nct_id": "NCT03225170", "title": "Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Self Affirmation (SA)", "type": "BEHAVIORAL" }, { "name": "Control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "National Human Genome Research Institute (NHGRI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 64, "start_date": "2017-08-15", "completion_date": "2020-06-29", "has_results": true, "last_update_posted_date": "2024-05-29", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03225170" }, { "nct_id": "NCT01550783", "title": "Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atypical Squamous Cell of Undetermined Significance", "Cervical Carcinoma", "Cervical Intraepithelial Neoplasia Grade 2/3", "Health Status Unknown", "Human Papillomavirus Infection", "Low Grade Cervical Squamous Intraepithelial Neoplasia", "Stage 0 Cervical Cancer" ], "interventions": [ { "name": "Cervical Papanicolaou Test", "type": "OTHER" }, { "name": "Cytology Specimen Collection Procedure", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Screening Method", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 1335, "start_date": "2012-03", "completion_date": "2017-11-16", "has_results": false, "last_update_posted_date": "2020-07-31", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota • Seattle, Washington", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01550783" }, { "nct_id": "NCT05582369", "title": "Feel the Move: A Micro-Randomized Trial of a Text-Based Expectation-Setting Intervention to Increase Physical Activity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Physical Activity" ], "interventions": [ { "name": "Affective Rewards Messages", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2023-05-31", "completion_date": "2023-11-30", "has_results": false, "last_update_posted_date": "2024-06-25", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05582369" }, { "nct_id": "NCT03457402", "title": "Shaping Tolerance for Delayed Rewards", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Impulsivity" ], "interventions": [ { "name": "Shaping Delay Tolerance", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "3 Years to 6 Years" }, "enrollment_count": 50, "start_date": "2017-09-12", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03457402" }, { "nct_id": "NCT04828551", "title": "Noninvasive Biomarkers of Metabolic Liver Disease 1.1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nonalcoholic Steatohepatitis", "Nonalcoholic Fatty Liver" ], "interventions": [ { "name": "Ultrasound based shear wave speed and fat quantification methods", "type": "DEVICE" }, { "name": "Blood collection", "type": "DIAGNOSTIC_TEST" }, { "name": "Physical measurements", "type": "OTHER" }, { "name": "Clinical history and medication reviews", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2021-03-18", "completion_date": "2021-11-20", "has_results": true, "last_update_posted_date": "2023-07-11", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 2, "location_summary": "San Diego, California • Boston, Massachusetts", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04828551" }, { "nct_id": "NCT02756572", "title": "Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Blasts 10 Percent or More of Bone Marrow Nucleated Cells", "Chronic Myelomonocytic Leukemia-2", "High Grade Malignant Neoplasm", "Myelodysplastic Syndrome", "Myelodysplastic Syndrome With Excess Blasts-2", "Myeloid Neoplasm", "Previously Treated Myelodysplastic Syndrome", "Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia" ], "interventions": [ { "name": "Cladribine", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Filgrastim", "type": "BIOLOGICAL" }, { "name": "Fludarabine Phosphate", "type": "DRUG" }, { "name": "Allogeneic Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Mitoxantrone Hydrochloride", "type": "DRUG" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Total-Body Irradiation", "type": "RADIATION" }, { "name": "Melphalan Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "PROCEDURE", "OTHER", "RADIATION" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2016-09-22", "completion_date": "2020-07-01", "has_results": true, "last_update_posted_date": "2021-11-08", "last_synced_at": "2026-11-11T21:39:54.652Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02756572" } ] }